510(k) K210983
K210983 is an FDA 510(k) premarket notification submitted by Becton, Dickinson and Company for the device "BD Epilor Syringe". The FDA issued a decision of Substantially Equivalent on May 19, 2022. The device falls under product code CAZ (Anesthesia Conduction Kit), a Class II device regulated under 21 CFR 868.5140. Becton, Dickinson and Company has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 19, 2022
- Date Received
- April 1, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Anesthesia Conduction Kit
- Device Class
- Class II
- Regulation Number
- 868.5140
- Review Panel
- AN
- Submission Type
This product code has been established in accordance with the May 20, 1997, Guidance entitled, Convenience Kits Interim Regulatory Guidance, found at www.fda.gov/cdrh/ode/convkit.html. This type of convenience kit, as listed in the guidance above, is under enforcement discretion, and does not require a premarket notification (510(k)) to market if it meets all criteria in the guidance.